Lupin rolls out generic oncology drug in US market
Drug firm Lupin has launched a generic cancer treatment medication in the US. The company introduced Dasatinib Tablets i...
Drug firm Lupin has launched a generic cancer treatment medication in the US. The company introduced Dasatinib Tablets i...
Finance Minister Nirmala Sitharaman announced plans for five regional medical tourism hubs. A Rs 10,000 crore Biopharma ...
The Union Budget 2026-27 signals a major policy shift, focusing on healthcare as a key economic growth driver. Finance M...
This could finally be the start of the drugmaker's comeback.
Spanish scientists have created a new triple drug therapy that completely cures pancreatic cancer in mice. This experime...
Indoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medicat...
Starting May 1, 2026, Canada's Interim Federal Health Program will introduce co-payments for certain health services. El...
The government is looking to control the sale of Pregabalin. This common medicine is being misused. The government wants...
Indian pharma leaders are urging the government for increased research and development incentives in the upcoming Union ...
Union Budget 2026: Indian pharmaceutical and healthcare leaders are urging the government to prioritize enhanced R&D inc...